Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Targeting LPA could help treat skin disorders.

Delivering IGF-1 with PLGA microspheres improves stem cell regeneration for tissues.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

The enzyme PA-PLA1α is important for proper hair follicle development.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

The new gel effectively treats psoriasis with minimal side effects.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

p2y5, now called LPA6, is a receptor important for human hair growth.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.